American Patent Law Association 
SUITE 20J . 2001 JEFFERSON DAVIS HIGHWAY. ARLINGTON, VA. 22202 
Telephone (?03) $21-1680 
October 20, 1976 
Reply to: 
800 N. Lindbergh Blvd. 
St. Louis, Missouri 63166 
Prnidtat 
John D. Uiham 
Pniidt*l-EUrl 
Donald V. Bannia 
III Vi er-Prtiidrnl 
Tom Aanolo 
2*4 Virt-Prriidrnl 
Donald R. Dvnnia 
Donald S. Fredrickson, M.D. 
Director 
Department of Health, Education, 
and Welfare 
Public Health Service 
National Institutes of Health 
Bethesda, Maryland 20014 
Stcrttery 
Maagaait M. Uvmnci 
T tttnrrr 
Fdwaad J. Bmnnii 
Re: HEW Patent Policy for 
Recombinant DNA Research 
Dear Dr. Fredrickson: 
Drtrf tit le ABA 
Ho uii of Dr U ft In 
V. Baovn Moaton. Ja. 
Co**eilmo* to NCPLA 
Faana L Niuhavaba 
Put Prtll4f*l 
Edvaad F. MrKrt, J*. 
Board of Mtnogtri 
The ibott penonj and 
Rouit T. Eoill 
Maicvi B. Finmican 
J imuoN D Gillia 
Thomas F. Smical, Ja. 
H. Faaoaka Ha mann 
Iattno t. Hatton 
D. Caal Richaaoa 
Haaaiat M ▼olpaon 
JcHBAH A. DiGaaNDI 
Jambs H. Laucmlin, Ja. 
Micmabl N. Mbllia 
Thomas E. Smith 
Etrnlm Drnclor 
Chaalottb E. Gauia 
The American Patent Law Association (APLA) 
membership, over 4,000, is made up of judges, law 
professors, and over one-half of the patent lawyers 
in the United States, engaged in private, corporate 
and government practice. 
After study and recommendations by our Govern- 
ment Patent Policy Committee, the Board of Managers of 
APLA adopted the following resolution: 
Responsive to the request of Donald S. 
Fredrickson, M.D., Director, Department 
of Health, Education and Welfare, Public 
Health Service, National Institutes of 
Health, in a letter dated September 7, 1976 
to the Manufacturing Chemists Association 
and other organizations, concerning patent 
applications in the area of recombinant DNA 
under Institutional Patent Agreements; 
Whereas , the Institutional Patent 
Agreements used by the Department of Health, 
Education and Welfare provide comprehensive 
safeguards for the public interest; and 
Whereas , the Institutional Patent Agreements 
and the incentives of the patent system do 
not unreasonably inhibit the rapid and full 
disclosure of research results; 
[ 145 ] 
